Molar Pregnancy in Nnamdi Azikiwe University Teaching Hospital, Nnewi, Nigeria: a 10 -Year Review
DOI:
https://doi.org/10.60787/njgp.v22i2.233Keywords:
Molar pregnancy, Prevalence, NAUTH NnewiAbstract
Background: Molar pregnancy, also known as hydatidiform mole, is a type of gestational trophoblastic disorder that normally arises from disorders of placental trophoblastic tissue proliferation. If not properly managed, it can be an important cause of maternal morbidity and mortality.
Objective: This study was to determine the prevalence and clinical outcome of molar pregnancies in Nnamdi Azikiwe University Teaching Hospital, Nnewi, Nigeria.
Materials and Methods: This is a retrospective study of all cases of molar pregnancies managed in Nnamdi Azikiwe University Teaching Hospital (NAUTH), Nnewi, South-east Nigeria, from January 1, 2012 to December 31, 2021 (ten-year period). Folders of patient managed for molar pregnancy during the study period served as source of data. Data were analyzed using Statistical Package for the Social Sciences (SPSS) 26.0 IBM Corporation.
Result: A total of 56 cases of molar pregnancies were diagnosed and managed within the 10-year review period, with a total delivery of 8194 giving a prevalence of 0.7% or 7 per 1000 deliveries. Within the same period, there were 5892 gynaecological admissions and molar pregnancy accounted for 1%. The mean age of the patients was 29.4 ± 4.4 years, however, most of the patients (73%) were within the age range of 26-35 years. Most of the patients managed presented in their first trimester (73%) with the commonest presenting complaints being amenorrhoea (100%), vaginal bleeding (94%) and abdominal pain (77%). The commonest complication recorded was anaemia (92%) while ultrasonography was instrumental in the diagnosis of 92% of cases. Majority of the patients (96%) were treated through suction evacuation while 4% were offered hysterectomy. More than 80% of those treated for molar pregnancies used contraception afterward with most of them favouring the male barrier method. Only 69% of the patients were followed up for at least 6 months, while 8% of the patients were followed up for more than 6 months and 21% of the patients were lost to follow up. The case fatality rate for this study was 2%.
Conclusion: Molar pregnancy accounted for 1% of all gynaecological admissions with an incidence of 7 per 1000 deliveries. It continues to be a significant contributor to maternal mortality and morbidity at our facility. Early recognition, immediate referral, and appropriate management will go a long way to curb the maternal mortality and morbidity from molar pregnancy. Proper patient education and adequate patient follow-up should also be reinforced.
Downloads
References
De Franciscis P, Schiattarella A, Labriola D, et al. A partial molar pregnancy associated with a fetus with intrauterine growth restriction delivered at 31 weeks: A case report. J Med Case Rep. 2019;13(1):1-5. doi:10.1186/s13256-019-2150-4.
Tenney ME. Molar Pregnancy. Non-Obstetric Surg Dur Pregnancy. Published online 2019:335-354. doi:10.1007/978-3-319-90752-9_27
Albright BB, Shorter JM, Mastroyannis SA, Ko EM, Schreiber CA, Sonalkar S. Gestational Trophoblastic Neoplasia after Human Chorionic Gonadotropin Normalization Following Molar Pregnancy: A Systematic Review and Meta-analysis. Obstet Gynecol. 2020;135(1):12-23. doi:10.1097/AOG.0000000000003566
Ikechukwu OH, Usman HA, Onuegunam NS. A Five-Year Retrospective Study of Gestational Trophoblastic Disease at University of Maiduguri Teaching Hospital Maiduguri, Nigeria. Int J Sci Healthc Res. 2021;6(2):228-234. doi:10.52403/ijshr.20210441.
Ghassemzadeh S, Farci F, Kang M. Hydatidiform Mole. [Updated 2022 May 23]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK459155/
Tantengco OAG, De Jesus FCC, Gampoy EFS, Ornos EDB, Vidal MS, Cagayan MSFS. Molar pregnancy in the last 50 years: A bibliometric analysis of global research output. Placenta. 2021;112(July):54-61. doi:10.1016/j.placenta.2021.07.003
Simms-Stewart D, McDonald G, Fletcher H, et al. A review of molar pregnancy at the university hospital of the West Indies over a 16-year period. J Obstet Gynaecol (Lahore). 2013;33(3):298-300. doi:10.3109/01443615.2012.753420
Christopher U, Ago B, Efiok E, Ebughe G, Nnorom F. A Ten Year Review of Hydatidiform Mole in University of Calabar Teaching Hospital Nigeria. J Gynecol Obstet. 2015;3(4):88. doi:10.11648/j.jgo.20150304.14
Ajenifuja K, Akadiri O, Okunola T, Ajayi M, Bakare B, Onwudiegwu U. Outcomes and challenges in the management of gestational trophoblastic disease in a tertiary institution in Nigeria. Trop J Obstet Gynaecol. 2015;32(1):143-149. https://www.ajol.info/index.php/tjog/article/view/118195
Igwegbe A, Eleje G. Hydatidiform mole: A review of management outcomes in a tertiary hospital in south-east Nigeria. Ann Med Health Sci Res. 2013;3(2):210. doi:10.4103/2141-9248.113664
Goldstein DP, Berkowitz RS, Horowitz NS. Molar Pregnancy and Gestational Trophoblastic Neoplasia. Holland-Frei Cancer Med. Published online 2017:1-7. doi:10.1002/9781119000822.hfcm107
Almasi A, Almassinokiani F, Akbari P. Frequency of molar pregnancies in health care centers of Tehran, Iran. J ReprodInfertil. 2014;15(3):157-160
Lund H, Vyberg M, Eriksen HH, Grove A, Jensen AØ, Sunde L. Decreasing incidence of registered hydatidiform moles in Denmark 1999–2014. Sci Rep. 2020;10(1). doi:10.1038/s41598-020-73921-4
Yuk JS, Baek JC, Park JE, Jo HC, Park JK, Cho IA. Incidence of gestational trophoblastic disease in South Korea: A longitudinal, population-based study. PeerJ. 2019;2019(2):1-11. doi:10.7717/peerj.6490
Joneborg U, Folkvaljon Y, Papadogiannakis N, Lambe M, Marions L. Temporal trends in incidence and outcome of hydatidiform mole: a retrospective cohort study. Acta Oncol (Madr). 2018;57(8):1094-1099. doi:10.1080/0284186X.2018.1438653
Ross JA, Unipan A, Clarke J, Magee C, Johns J. Ultrasound diagnosis of molar pregnancy. Ultrasound. 2018;26(3):153-159. doi:10.1177/1742271X17748514
Zakaria A, Hemida R, Elrefaie W, Refaie E. Incidence and outcome of gestational trophoblastic disease in lower Egypt. African health sciences. 2020 Apr 20;20(1):73-82
Yakasai I. Gestational Trophoblastic Diseases in a Teaching Hospital in Northern, Nigeria. Am J Biosci. 2015;3(1):7. doi:10.11648/j.ajbio.20150301.12
Kolawole A, Nwajagu J, Oguntayo A, Zayyan M, Adewuyi S. Gestational trophoblastic disease in Abuth Zaria, Nigeria: A 5-year review. Trop J Obstet Gynaecol. 2016;33(2):209. doi:10.4103/0189-5117.192228
Wairachpanich V, Limpongsanurak S, Lertkhachonsuk R. Epidemiology of hydatidiform moles in a Tertiary Hospital in Thailand over two decades: Impact of the national health policy. Asian Pacific J Cancer Prev. 2016;16(18):8321-8325. doi:10.7314/APJCP.2015.16.18.8321
Bw H. Management of Gestational Trophoblastic Disease: Green-top Guideline No. 38 – June 2020. BJOG An Int J Obstet Gynaecol. 2021;128(3):e1-e27. doi:10.1111/1471-0528.16266
Published
Issue
Section
License
Copyright (c) 2025 Nigerian Journal of General Practice

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.